Nexaph peptides represent a novel clinical strategy targeting illness progression. These engineered molecules leverage the unique properties of short peptide sequences to modulate cellular activities involved in reaction, tissue repair, and cancer growth. Investigations suggest their possibility for addressing a variety of chronic conditions, offer